GBT Announces Participation in Upcoming Investor Conferences
September 03 2020 - 8:00AM
Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced
that members of the senior management team will participate in
virtual fireside chats at the following investor conferences:
- Wells Fargo Securities 2020 Healthcare Conference on September
9 at 3:20 p.m. ET;
- H.C. Wainwright 22nd Annual Global Investment Conference on
September 14 at 10:00 a.m. ET;
- Morgan Stanley 18th Annual Global Healthcare Conference on
September 16 at 10:15 a.m. ET; and
- Cantor Fitzgerald Virtual Global Healthcare Conference on
September 17 at 11:20 a.m. ET.
The fireside chats will be webcast live from GBT’s website at
www.gbt.com in the Investors section. Replays of the webcast will
be archived and available for one month following each event.
About Global Blood TherapeuticsGlobal Blood
Therapeutics (GBT) is a biopharmaceutical company dedicated to
the discovery, development, and delivery of life-changing
treatments that provide hope to underserved patient communities.
Founded in 2011, GBT is delivering on its goal to transform the
treatment and care of sickle cell disease (SCD), a lifelong,
devastating inherited blood disorder. The company has introduced
Oxbryta® (voxelotor), the first FDA-approved treatment that
directly inhibits sickle hemoglobin polymerization, the root cause
of red blood cell sickling in SCD. GBT is also advancing its
pipeline program in SCD with inclacumab, a p-selectin inhibitor in
development to address pain crises associated with the disease. In
addition, GBT’s drug discovery teams are working on new targets to
develop the next generation of treatments for SCD. To learn more,
please visit www.gbt.com and follow the company on
Twitter @GBT_news.
Contact Information:Steven Immergut
(media)650-410-3258simmergut@gbt.com
Stephanie Yao (investors) 650-741-7730 syao@gbt.com
Global Blood Therapeutics (NASDAQ:GBT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Global Blood Therapeutics (NASDAQ:GBT)
Historical Stock Chart
From Sep 2023 to Sep 2024